Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications. The biotechnology company said the FDA put a hold on its Ebvallo and ATA3219 programs due to compliance issues at a third-party manufacturing facility.
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and adaptability
Federal officials Wednesday released a far-reaching proposal to make cigarettes less addictive by capping their nicotine content.
Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming administration will offer support.
A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far less addictive by reducing their nicotine content.
The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application
In the final days of President Joe Biden’s term, the US Food and Drug Administration (FDA) has placed a proposal that could make cigarettes less addictive and simpler to quit. The agency says it will drastically reduce the amount of nicotine levels in cigarettes,
The Food and Drug Administration OK'd 10 Zyn flavors, including coffee, mint and menthol. It's the first time regulators have authorized sales of nicotine pouches, which are the fastest-growing segment of the U.S. tobacco market.
The U.S. Food and Drug Administration has issued a proposed rule that, if finalized, would make cigarettes and certain other combusted tobacco
Robert F. Kennedy Jr. has big plans for the FDA if he's confirmed as Secretary of Health and Human Services. FDA Commissioner Robert Califf explains why certain changes may not be that easy — or desirable.
FDA wants pet food manufacturers to do a better job identifying possible signs of bird flu in raw foods such as uncooked meat or unpasteurized eggs
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday.